chr5-149601204-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001669.3(ARHGEF37):āc.283A>Cā(p.Lys95Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001669.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF37 | NM_001001669.3 | c.283A>C | p.Lys95Gln | missense_variant | 3/13 | ENST00000333677.7 | NP_001001669.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF37 | ENST00000333677.7 | c.283A>C | p.Lys95Gln | missense_variant | 3/13 | 2 | NM_001001669.3 | ENSP00000328083 | P1 | |
ARHGEF37 | ENST00000505810.5 | c.283A>C | p.Lys95Gln | missense_variant | 3/3 | 5 | ENSP00000425621 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 249470Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135336
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1460644Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726464
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | The c.283A>C (p.K95Q) alteration is located in exon 3 (coding exon 2) of the ARHGEF37 gene. This alteration results from a A to C substitution at nucleotide position 283, causing the lysine (K) at amino acid position 95 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at